Phase 2 and Phase 3 trials of the AstraZeneca Oxford coronavirus vaccine has been halted.
A standard review process has been triggered, leading to the voluntary pause of vaccination across all trials to allow the safety measure that occurred in a single event of unexplained illness in the UK Phase III trial.
The Serum Institute of India, Oxford University, and the AstraZeneca were jointly conducting trials for the vaccine 'AZD1222'.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.